NASDAQ:RPID Rapid Micro Biosystems (RPID) Stock Price, News & Analysis $0.74 -0.14 (-15.91%) (As of 12/29/2023 ET) Add Compare Share Share Today's Range$0.74▼$0.9050-Day Range$0.74▼$1.1752-Week Range$0.74▼$1.55Volume1.18 million shsAverage Volume62,216 shsMarket Capitalization$31.38 millionP/E RatioN/ADividend YieldN/APrice Target$2.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Rapid Micro Biosystems MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside271.6% Upside$2.75 Price TargetShort InterestHealthy0.08% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.61Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.28) to ($1.15) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.17 out of 5 starsMedical Sector458th out of 950 stocksAnalytical Instruments Industry12th out of 26 stocks 3.0 Analyst's Opinion Consensus RatingRapid Micro Biosystems has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.75, Rapid Micro Biosystems has a forecasted upside of 271.6% from its current price of $0.74.Amount of Analyst CoverageRapid Micro Biosystems has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.08% of the float of Rapid Micro Biosystems has been sold short.Short Interest Ratio / Days to CoverRapid Micro Biosystems has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rapid Micro Biosystems has recently increased by 65.93%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldRapid Micro Biosystems does not currently pay a dividend.Dividend GrowthRapid Micro Biosystems does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RPID. Previous Next 2.6 News and Social Media Coverage News SentimentRapid Micro Biosystems has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Rapid Micro Biosystems this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Rapid Micro Biosystems to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rapid Micro Biosystems insiders have not sold or bought any company stock.Percentage Held by Insiders32.39% of the stock of Rapid Micro Biosystems is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions51.67% of the stock of Rapid Micro Biosystems is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Rapid Micro Biosystems are expected to grow in the coming year, from ($1.28) to ($1.15) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rapid Micro Biosystems is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rapid Micro Biosystems is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRapid Micro Biosystems has a P/B Ratio of 0.19. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Rapid Micro Biosystems Stock (NASDAQ:RPID)Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, onsite technical training, and customer support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. In addition, it offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; and RMBNucleus Central Manager portal streamlines monitoring and reporting. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.Read More RPID Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RPID Stock News HeadlinesDecember 29, 2023 | americanbankingnews.comRapid Micro Biosystems (NASDAQ:RPID) Stock Price Down 0.6%December 15, 2023 | msn.comRapid Micro Biosystems files for $200M mixed shelfDecember 31, 2023 | MarketBeat Internal (Ad)MarketBeat All Access New Year's Sale - Just $1.00Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Save 75% Your 2024 Subscription. Just $1.00 for the first 30 days.November 7, 2023 | finance.yahoo.comRapid Micro Biosystems to Participate in Upcoming Investor ConferencesNovember 5, 2023 | finance.yahoo.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2023 Earnings Call TranscriptNovember 3, 2023 | msn.comRapid Micro Biosystems GAAP EPS of -$0.31, revenue of $6.1MNovember 3, 2023 | finance.yahoo.comRapid Micro Biosystems Reports Third Quarter 2023 Financial ResultsNovember 3, 2023 | finance.yahoo.comRapid Micro Biosystems Inc (RPID) Reports 30% Revenue Growth in Q3 2023December 31, 2023 | MarketBeat Internal (Ad)MarketBeat All Access New Year's Sale - Just $1.00Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Save 75% Your 2024 Subscription. Just $1.00 for the first 30 days.October 19, 2023 | finance.yahoo.comRapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023September 29, 2023 | finance.yahoo.comRapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4September 19, 2023 | finance.yahoo.comRapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company ShowcaseSeptember 10, 2023 | finance.yahoo.comInsider Buying: CFO Sean Wirtjes Acquires 10,000 Shares of Rapid Micro Biosystems IncSeptember 6, 2023 | finance.yahoo.comRapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare ConferenceAugust 4, 2023 | finance.yahoo.comQ2 2023 Rapid Micro Biosystems Inc Earnings CallAugust 4, 2023 | finance.yahoo.comRapid Micro Biosystems Reports Second Quarter 2023 Financial ResultsAugust 4, 2023 | finance.yahoo.comRapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue EstimatesAugust 3, 2023 | benzinga.comRapid Micro Biosystems's Earnings OutlookJuly 20, 2023 | finance.yahoo.comRapid Micro Biosystems to Announce Second Quarter 2023 Financial Results on August 4, 2023July 19, 2023 | finanznachrichten.deRapid Micro Biosystems, Inc.: Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of DirectorsJuly 18, 2023 | finance.yahoo.comRapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of DirectorsJuly 5, 2023 | finance.yahoo.comRapid Micro Biosystems, Inc. (RPID) Moves to Buy: Rationale Behind the UpgradeMay 9, 2023 | finance.yahoo.comRapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 6, 2023 | finance.yahoo.comQ1 2023 Rapid Micro Biosystems Inc Earnings CallMay 5, 2023 | finanznachrichten.deRapid Micro Biosystems, Inc.: Rapid Micro Biosystems Reports First Quarter 2023 Financial ResultsMay 5, 2023 | msn.comRapid Micro Biosystems: Q1 Earnings InsightsMay 5, 2023 | finance.yahoo.comRapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue EstimatesSee More Headlines Receive RPID Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rapid Micro Biosystems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/03/2023Today12/31/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/01/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Analytical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:RPID CUSIPN/A CIK1380106 Webwww.rapidmicrobio.com Phone978-349-3200FaxN/AEmployees177Year FoundedN/APrice Target and Rating Average Stock Price Target$2.75 High Stock Price Target$2.75 Low Stock Price Target$2.75 Potential Upside/Downside+271.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-60,810,000.00 Net Margins-280.90% Pretax Margin-280.76% Return on Equity-39.55% Return on Assets-34.22% Debt Debt-to-Equity RatioN/A Current Ratio7.37 Quick Ratio6.07 Sales & Book Value Annual Sales$17.13 million Price / Sales1.83 Cash FlowN/A Price / Cash FlowN/A Book Value$3.90 per share Price / Book0.19Miscellaneous Outstanding Shares42,400,000Free Float28,666,000Market Cap$31.38 million OptionableNot Optionable Beta1.29 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Robert G. Spignesi Jr. (Age 53)CEO, President & Director Comp: $777.53kMr. Sean M. Wirtjes (Age 54)Chief Financial Officer Comp: $510.64kMr. John J. Addington Wilson (Age 55)Chief Operating Officer Comp: $512.94kMichael Beaulieu C.F.A.Vice President of Investor Relations & Corporate CommunicationsMr. Michael WysockiSenior Vice President of Sales & MarketingMs. Victoria L. Vezina (Age 55)Chief Human Resources Officer Comp: $366.36kMs. Kristine WilliamsSenior Vice President of Research & Development and Product ManagementMore ExecutivesKey CompetitorsSingular Genomics SystemsNASDAQ:OMICPrecision BioSciencesNASDAQ:DTILCue HealthNASDAQ:HLTHTalis BiomedicalNASDAQ:TLISTelesis BioNASDAQ:DNAYView All CompetitorsInsidersSean M WirtjesBought 10,000 shares on 9/6/2023Total: $9,900.00 ($0.99/share)Robert G Jr. SpignesiBought 20,000 shares on 8/15/2023Total: $19,400.00 ($0.97/share)Robert G Jr. SpignesiBought 20,000 shares on 5/17/2023Total: $18,200.00 ($0.91/share)View All Insider Transactions RPID Stock Analysis - Frequently Asked Questions Should I buy or sell Rapid Micro Biosystems stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rapid Micro Biosystems in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" RPID shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RPID, but not buy additional shares or sell existing shares. View RPID analyst ratings or view top-rated stocks. What is Rapid Micro Biosystems' stock price target for 2024? 1 Wall Street research analysts have issued twelve-month price objectives for Rapid Micro Biosystems' stock. Their RPID share price targets range from $2.75 to $2.75. On average, they anticipate the company's stock price to reach $2.75 in the next year. This suggests a possible upside of 271.6% from the stock's current price. View analysts price targets for RPID or view top-rated stocks among Wall Street analysts. How have RPID shares performed in 2023? Rapid Micro Biosystems' stock was trading at $1.13 at the beginning of the year. Since then, RPID stock has decreased by 34.5% and is now trading at $0.74. View the best growth stocks for 2023 here. When is Rapid Micro Biosystems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, March 1st 2024. View our RPID earnings forecast. How were Rapid Micro Biosystems' earnings last quarter? Rapid Micro Biosystems, Inc. (NASDAQ:RPID) issued its quarterly earnings results on Friday, November, 3rd. The company reported ($0.31) earnings per share for the quarter, beating analysts' consensus estimates of ($0.32) by $0.01. The firm earned $6.15 million during the quarter, compared to analyst estimates of $5.53 million. Rapid Micro Biosystems had a negative trailing twelve-month return on equity of 39.55% and a negative net margin of 280.90%. During the same quarter in the prior year, the firm posted ($0.38) EPS. When did Rapid Micro Biosystems IPO? (RPID) raised $125 million in an initial public offering on Thursday, July 15th 2021. The company issued 6,600,000 shares at a price of $18.00-$20.00 per share. How do I buy shares of Rapid Micro Biosystems? Shares of RPID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RPID) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapid Micro Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.